VANDELLI, Carmen
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.337
EU - Europa 1.549
AS - Asia 1.338
SA - Sud America 175
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 6.440
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.289
SG - Singapore 447
GB - Regno Unito 365
PL - Polonia 318
CN - Cina 307
SE - Svezia 208
HK - Hong Kong 180
IT - Italia 178
VN - Vietnam 171
BR - Brasile 127
DE - Germania 123
FI - Finlandia 97
TR - Turchia 82
RU - Federazione Russa 63
UA - Ucraina 61
BD - Bangladesh 39
FR - Francia 37
BG - Bulgaria 26
NL - Olanda 24
IN - India 22
CA - Canada 21
AR - Argentina 19
KR - Corea 17
IQ - Iraq 15
ZA - Sudafrica 15
BE - Belgio 13
MX - Messico 12
EC - Ecuador 9
CO - Colombia 8
JP - Giappone 8
CZ - Repubblica Ceca 7
ID - Indonesia 7
IE - Irlanda 7
KE - Kenya 7
MA - Marocco 6
MY - Malesia 5
PH - Filippine 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
EG - Egitto 4
IL - Israele 4
PY - Paraguay 4
RO - Romania 4
AT - Austria 3
AZ - Azerbaigian 3
CR - Costa Rica 3
ES - Italia 3
JM - Giamaica 3
LT - Lituania 3
UZ - Uzbekistan 3
VE - Venezuela 3
AL - Albania 2
DZ - Algeria 2
EU - Europa 2
GD - Grenada 2
IR - Iran 2
LB - Libano 2
MN - Mongolia 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
AU - Australia 1
BH - Bahrain 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HN - Honduras 1
JO - Giordania 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.440
Salva come PNG Salva come JPEG
Città #
Santa Clara 322
Warsaw 313
Ashburn 297
Fairfield 284
Singapore 250
Southend 229
Woodbridge 222
Chandler 198
Houston 178
Hong Kong 176
Ann Arbor 127
Wilmington 127
Jacksonville 120
San Jose 100
Nyköping 97
Dearborn 89
Chicago 87
Seattle 86
Cambridge 79
Los Angeles 79
Helsinki 69
London 64
Beijing 63
Hefei 50
Izmir 50
Ho Chi Minh City 48
Hanoi 46
Salt Lake City 37
Moscow 32
New York 32
San Diego 32
Princeton 30
Council Bluffs 27
Sofia 26
The Dalles 26
Des Moines 25
Eugene 25
Lauterbourg 23
Shanghai 21
Boardman 19
Munich 19
Dallas 18
Milan 17
Modena 17
Buffalo 16
São Paulo 16
Amsterdam 15
Seoul 15
Tampa 15
Frankfurt am Main 13
Brussels 11
Haiphong 11
Lancaster 11
Sterling 11
Johannesburg 9
Orem 9
Reggio Nell'emilia 9
Da Nang 8
Elk Grove Village 8
Falls Church 8
Phoenix 8
Dublin 7
Falkenstein 7
Tokyo 7
Brooklyn 6
Guangzhou 6
Miano 6
Nairobi 6
Redwood City 6
Rome 6
San Mateo 6
Atlanta 5
Bologna 5
Bremen 5
Miami 5
Montreal 5
Quito 5
Rio de Janeiro 5
Xi'an 5
Auburn Hills 4
Baghdad 4
Brno 4
Córdoba 4
Denver 4
Detroit 4
Dhaka 4
Groningen 4
Hải Dương 4
Jersey City 4
Kansas City 4
Kunming 4
Mexico City 4
Newark 4
Norwalk 4
Porto Alegre 4
Toronto 4
Turku 4
Ankara 3
Asunción 3
Augusta 3
Totale 4.653
Salva come PNG Salva come JPEG
Nome #
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 624
Lack of evidence of sexual transmission of hepatitis C among monogamous couples: Results of a 10-year prospective follow-up study 364
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV 322
Genetic polymorphisms of interleukin-6 modulates fibrosis progression in mild chronic hepatitis C. 309
Apolipoprotein E genotypes modulate fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases 306
A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon 301
The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naive hepatitis C patients. 297
Fibrosis progression in HCV carriers with mild hepatitis who possess the high-repetition variant of the DRD4 gene, a genetic marker for binge-drinking and risk-seeking behavior: a longitudinal study 272
Parametri predittivi e risposta sostenuta alla terapia antivirale combinata nell'epatite cronica attivva HCV correlata (ECA HCV) 258
Chronic hepatitis C and psychosocial distress 253
Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy 241
Demographic, etiological and clinical features of liver cirrhosis at the onset of the first episode of clinical decompensation: Preliminary results of the “A.I.S.F.-EPASCO” Study. 236
Efficacy and safety of increasing doses of the cyclophilin inhibitor Debio 025 in combination with pegylated Interferon alpha-2a in treatment naïve mono-infected HCV patients. 43rd Annual Meeting of the European Association for the Study of the Liver (EASL). Milano,Italia, 23-27 Aprile, 2008. 236
The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases 207
Efficacy and safety of increasing doses of the cyclophilin inhibitor Debio 025 in combination with pegylated Interferon alpha-2a in treatment naïve mono-infected HCV patients. 206
Analysis of factors involved in fibrosis progression among hepatitis C virus carriers with normal alanine aminotransferares. 41st Annual Meeting of the European Association for the Study of the Liver (EASL).Vienna, Austria, 26-30 Aprile 2006. 203
Long-term interferon therapy in patients with refractory chronic hepatitis C: effect on histological liver damage and hepatocellular carcinogenesis. 199
Demographic, etiological and clinical features of liver cirrhosis at the onset of the first episode of clinical decompensation: Preliminary results of the “A.I.S.F.-EPASCO” 198
Health-related quality of life in recent and long standing chronic HCV infection. 195
Hepatitis C virus carriers with normal alanine aminotransferases: analysis of factors involved in fibrosis progression. 42nd Annual Meeting of the European Association for the Study of the Liver (EASL). Barcellona, Spagna, 11-15 aprile 2007. 193
Demographic, etiological and clinical features of 500 consecutive patients with liver cirrhosis at the onset of the first episode of decompensation. 50th Anniversary Meeting of the International Association for the Study of Liver Diseases (AASLD). San Francisco, 31 Ottobre- 4 Novembre 2008. 188
Demographic, etiological and clinical features of 500 consecutive patients with liver cirrhosis at the onset of the first episode of decompensation. 50th Anniversary Meeting of the International Association for the Study of Liver Diseases (AASLD) 185
Metodologia per l’adozione di linee guida cliniche in Medicina Interna. 181
Prediciting the natural history of patients with epatitis C and persistently normal transaminases: a longitudinal long term study with dual biopsies. 43rd Annual Meeting of the European Association for the Study of the Liver (EASL). 180
The virologic and histologic status in anti HCV+ve subjects with normal ALT levels: results of a ten year prospective follow-up study. 170
Prediciting the natural history of patients with epatitis C and persistently normal transaminases: a longitudinal long term study with dual biopsies. 43rd Annual Meeting of the European Association for the Study of the Liver (EASL). Milano, Italia, 23-27 Aprile, 2008. 141
Prediction of successful outcome in a randomised controlled trial of the long-term efficacy of interferon alpha treatment for chronic hepatitis C 2
Totale 6.467
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.809
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.809
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022476 9 58 50 59 13 24 26 13 56 34 90 44
2022/2023526 61 68 36 46 63 92 3 52 84 2 11 8
2023/2024318 8 21 14 32 49 19 52 79 6 2 11 25
2024/20251.035 36 13 7 137 221 150 60 32 136 46 71 126
2025/20262.156 85 53 95 211 448 453 230 98 193 139 67 84
2026/20272 2 0 0 0 0 0 0 0 0 0 0 0
Totale 6.467